Bioprocessing systems Go Disposable

摘要

Single-use disposable technology is gaining acceptance in the biopharmaceutical arena,especially with processors seeking to reduce their operating costs and add flexibility to their manufacturing schemes."For bioreactors,the initial investment cost with the disposable systems - at clinical manufacturing (200-2,000 L) and commercial manufacturing (>2,OOOL) scales - is approximately half the costs associated with conventional bioreactors," says Robert Dream,director of pharmaceutical/biotechnology,Europe,for CH2M HILL Lockwood Greene (www.lg.com).